Recent Headlines
Within Biotechnology
SFL Appoints Advisory Board
SFL announces details of its Advisory Board. - March 22, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
F2G Ltd Appoints Ian Nicholson as Chief Executive Officer
F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors. - March 20, 2013 - F2G Ltd
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine
Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol - March 19, 2013 - Arbovax Inc
Stevens Professor Joins Open Source Effort to Develop Low-Cost Drugs
Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative. Dr. Ganguly is focusing on new treatments for malaria and tuberculosis, which are causing millions of deaths while several drugs used to cure these diseases no longer work because of the appearance of resistant strains. - March 16, 2013 - Stevens Institute of Technology
The Jon Block Group to Participate in 2013 AAOS Annual Meeting
The Jon Block Group announced they will be participating in the 2013 annual meeting of the American Academy of Orthopaedic Surgeons, taking place in Chicago from March 19-23, 2013. The Group will be meeting with several orthopedic firms to discuss clinical strategies specifically associated with... - March 13, 2013 - Jon Block Group
Bioo Scientific Launches Kit for Affordable Screening of Enrofloxacin Contamination in Seafood
Bioo Scientific’s just released the MaxSignal® Enrofloxacin ELISA Test Kit to rapidly screen fish and shrimp for enrofloxacin and ciprofloxacin. - March 11, 2013 - Bioo Scientific
Promoters for Improved Protein & Biopharmaceutics Production in Mammalian Cells
Synpromics Ltd, the synthetic promoter company, announces the award by the Technology Strategy Board, the UK’s innovation agency, of an over £240,000 grant under the TSB’s Synthetic Biology initiative to a consortium led by Synpromics and also including Genabler Ltd and the University of Edinburgh’s SynthSys Centre for Synthetic and Systems Biology. - March 09, 2013 - Synpromics Ltd
GoldBio Launches New Product Line: Growth Factors and Stem Cell Reagents
Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents. - March 07, 2013 - Gold Biotechnology, Inc
GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services
GenWay Biotech announces Ruben Flores-Saaib, PhD as Vice President of Custom and Catalog Services assuming responsibilities for the Company's custom services and catalog business operating activities. - March 06, 2013 - GenWay Biotech
The CytoPatch™2: Faster, Cheaper, and More Powerful
Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the release of the second generation GLP compliant CytoPatch™ instrument, the CytoPatch2. - March 06, 2013 - Cytocentrics
Acoustics Expert Dr. Prasad Gives Keynote Presentation at International Conference
Professor Marehalli Prasad advocates better design to reduce environmental noise. - March 02, 2013 - Stevens Institute of Technology
MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure™
MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™. TrialAssure™ is a workflow management system that supports the reporting of... - March 02, 2013 - MMS Holdings Inc.
SFL Experts to Present and Chair Sessions at the 2013 DIA Annual EuroMeeting
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at DIA EuroMeeting in Amsterdam. - March 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Ohio State and Biosortia Pharmaceuticals to Join Forces to Discover Anti-Cancer Compounds
The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to discover new biologically active natural products with potential anti-cancer activity. Potential candidate compounds discovered during the Biosortia-sponsored research project will primarily be tested against human colon cancer assays. The ultimate goal is to obtain lead compounds that can be licensed to and developed by pharmaceutical companies through Biosortia’s pharmaceutical relationships. - February 28, 2013 - Biosortia Pharmaceuticals
Dr. Chandramouli Named IEEE Communications Society Distinguished Lecturer for 2013 and 2014
Stevens professor breaks down cell phone network barriers and evaluates effects of social networks. - February 27, 2013 - Stevens Institute of Technology
New Efficient Reagent for Stem Cell Transfection
DreamFect™ Stem transfection reagent from Oz Biosciences is specifically developed for transfection of Stem Cell. - February 23, 2013 - OZ Biosciences
OsoBio President to Join Injectable Trends Discussion at DCAT Week
OsoBio President Milton Boyer and other experts will examine industry's shortages. - February 22, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
MD Stem Cells: Very Elderly Benefit from Stem Cells for Macular Degeneration
92 year old shows rapid vision results with stem cells. Age is not a barrier to visual improvement following stem cell treatment reports MD Stem Cells. - February 21, 2013 - MD Stem Cells
EECP Therapy Has Helped Raise Awareness and Made a Difference in the Lives of Heart Patients
Eastern Connecticut Cardiology Associates Announces its Participation in National EECP® Therapy Week - February 17, 2013 - International EECP Therapist Association
Connecticut Cardiology Practice Invites Patients to their Open House to Raise Heart Awareness
Hartford Cardiology Group, LLC Announces its Participation in National EECP® Therapy Week. - February 17, 2013 - International EECP Therapist Association
For People Who Suffer from Angina, There is “Hope” Available
EECP Center of Pittsburgh Announces its Participation in National EECP® Therapy Week - February 17, 2013 - International EECP Therapist Association
Cambridge Healthtech Institute & Bio-IT World Announces Program for Its 13th Annual Structure-Based Drug Design Conference, June 19-21, 2013, Boston, MA
Featuring Keynote from Aileron Therapeutics’ Tomi Sawyer - February 16, 2013 - Cambridge Healthtech Institute
In Tribute of American Heart Month, an Ohio Cardiology Practice Promotes Heart Awareness in a Special Way
Dayton Heart Center Announces its Participation in National EECP® Therapy Week. - February 15, 2013 - International EECP Therapist Association
MD Stem Cells Begins Intravitreal Stem Cell Treatments for Severe Visual Loss
New Intravitreal Stem Cell Injection Approach to Improve Vision is Now Available through MD Stem Cells. - February 15, 2013 - MD Stem Cells
Xeno Diagnostics, LLC Receives Award for Laboratory Excellence
Xeno Diagnostics, LLC Recognized for Quality Laboratory Services - February 15, 2013 - Xeno Diagnostics, LLC
Greenwerkz Releases R4 Ultra-High CBD, Non-Psychoactive Strain as "Open Source"
Greenwerkz' high CBD/low THC strain genetics to become available to patients and medical marijuana centers (MMCs) in Colorado, free of charge. - February 14, 2013 - Greenwerkz
IonSense to Present Direct Analysis in Real Time (DART®) Analysis for Rapid Drug Screening at the American Academy of Forensic Sciences (AAFS) 65th Annual Meeting
IonSense will present its DART-MS technology for rapid screening of urine samples using solid phase microfiber probes, enabling sample inspection for drugs of abuse in minutes. This is the first time IonSense will exhibit at the AAFS meeting, February 18-23, 2013 in Washington, D.C., Booth 405. - February 14, 2013 - IonSense, Inc.
Local Cardiac Rehab Center Will Provide a Free Service to Help Raise Heart Awareness for American Heart Month
Health Enhancement Cardiac Rehab Centers Announces its Participation in National EECP® Therapy Week. - February 14, 2013 - International EECP Therapist Association
Raising Heart Awareness in February has Special Significance for Local Hospital
Advocate Christ Medical Center Announces its Participation in National EECP® Therapy Week. - February 14, 2013 - International EECP Therapist Association
Local Cardiology practice Raises Heart Awareness for American Heart Month
Heart Centers of America Announces its Participation in National EECP® Therapy Week. - February 13, 2013 - International EECP Therapist Association
SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013. - February 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
National Simultaneous Red Balloon Release Raises Heart Awareness for American Heart Month
Ohio Heart and Vascular Center Announces Its Participation in National EECP® Therapy Week - February 10, 2013 - International EECP Therapist Association
Creagri, Inc. Announces a Strategic Distribution Agreement for Olivenol® Plus Line of Dietary Supplements and Skincare Products
Creagri, Inc., and NewWave Biosciences, Inc., announced today that they have reached an agreement for the distribution of Olivenol® plus products across the therapeutic channel. - February 09, 2013 - Creagri, Inc.
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits
AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, is Offering Glycan Arrays for Multiple Analysis of Glycan-Related Interactions
MoBiTec Germany, in cooperation with the Japanese company Sumitomo Bakelite Co. Ltd., is offering to its European customers Glycan Arrays that are useful for studies on the interaction of microorganisms, analysis of glycan-binding proteins, autoantibodies and more. - February 09, 2013 - MoBiTec GmbH
ImmunoReagents Enters Distributorship Agreement with Abyntek Biopharma; Key Spanish Supplier of Antibodies
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain. ImmunoReagents and Abyntek will partner to distribute top quality antibodies and... - February 08, 2013 - ImmunoReagents Inc.
BANG® – as Official Energy Drink of NHL Florida Panthers & BB&T Center
It was just announced that VPX’s BANG® will be named official energy drink of the NHL Florida Panthers and the BB&T Center, formerly known as the Bank Atlantic Center. - February 07, 2013 - VIRUN
Billion Cell Milestone Reached in Stem Cell Treatment
MD Stem Cells Reports Almost Two Billion Cells Used in Eye Stem Cell Treatment in Florida. - February 07, 2013 - MD Stem Cells
Bioo Scientific Releases NEXTflex™ 16S V4 Amplicon-Seq Kit for Bacterial Metagenomics Studies
The NEXTflex™ 16S V4 Amplicon-Seq Kit has been developed to simplify bacterial metagenomics studies using Illumina® HiSeq and MiSeq platforms. This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available. Using specialized NEXTflex... - February 06, 2013 - Bioo Scientific
Molecular Medicine Tri-Conference 2013 - Complimentary Hall Passes Now Available
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference (Triconference.com/hallpass) - February 02, 2013 - Cambridge Healthtech Institute
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
Colorado BioScience Association Focuses on 2013's Key State and Federal Legislative Initiatives at Fifth Annual "BioScience Day at the Capitol"
Colorado BioScience Association (CBSA) is hosting its fifth annual "BioScience Day at the Capitol" on January 30. The event will feature Mark Leahey, President and CEO, Medical Device Manufacturers Association (MDMA) presenting the "State of the Medical Device Industry" and efforts MDMA is leading in Washington to repeal the Medical Device Tax. - January 28, 2013 - Colorado BioScience Association
CHI Releases List of Delegates for Targeting Cancer Stem Cells Symposium in San Francisco, CA
To be held on February 11-12, 2013 at the Moscone North Convention Center, San Francisco, CA - Part of the Molecular Med TRI-CON 2013. - January 26, 2013 - Cambridge Healthtech Institute
Tampa Bay Surgeons Offer Virtually Scarless Weight-Loss Procedure
Sun Coast Bariatrics is using the SPIDER® Surgical System to perform single-incision sleeve gastrectomy. - January 26, 2013 - TransEnterix
IonSense Awarded Massachusetts Workforce Training Grant. Adds New Sales Management.
IonSense, Inc. announced that they are a recipient of one of the 87 Workforce Training Grants awarded by the state of Massachusetts. This grant will enable the company to provide training to a number of employees in the areas of software development and engineering. “We are growing our... - January 25, 2013 - IonSense, Inc.
Optic Nerve Vision Loss Reversed with New Stem Cell Treatment
MD Stem Cells helps nearly blind car accident victim regain her sight in Florida and see her mother’s face again- other neurologic benefits reported as well. - January 24, 2013 - MD Stem Cells
Stevens Undergraduates Present Research on Reducing Back Pain
Lower back pain is the second most common cause of disability for adults in the United States. Faced with the rising number of individuals suffering from the condition, undergraduate students Emily Noonan and Hanna Sidoti at the Stevens Institute of Technology will be presenting their research on... - January 24, 2013 - Stevens Institute of Technology
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
Stevens Students Enter National Academy of Engineering Ethics Video Contest
Team of engineers proposes reassessment of nuclear energy as a sustainable power source as part of the National Academy of Engineering (NAE) Online Ethics Center (OEC) Energy Ethics Video Challenge. - January 16, 2013 - Stevens Institute of Technology
MD Stem Cells Improves Myopic Macular Degeneration with New Stem Cell Treatment
MD Stem Cells helps Australian patient travel half way around the world for stem cell treatment in Florida to achieve significant improvement in vision. - January 14, 2013 - MD Stem Cells